|
GOLGA7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.421200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.852150E-01 |
| Normal-vs-Stage2 |
4.957200E-01 |
| Normal-vs-Stage3 |
2.00679999999842E-05 |
| Normal-vs-Stage4 |
4.11529999999605E-06 |
| Stage1-vs-Stage2 |
9.892400E-01 |
| Stage1-vs-Stage3 |
3.168600E-04 |
| Stage1-vs-Stage4 |
3.018700E-04 |
| Stage2-vs-Stage3 |
3.065600E-02 |
| Stage2-vs-Stage4 |
2.692400E-02 |
| Stage3-vs-Stage4 |
7.893000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.516900E-03 |
| Normal-vs-AfricanAmerican |
1.72799999997864E-06 |
| Normal-vs-Asian |
1.205390E-01 |
| Caucasian-vs-AfricanAmerican |
6.502700E-03 |
| Caucasian-vs-Asian |
2.870600E-01 |
| AfricanAmerican-vs-Asian |
7.420000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5363000000066E-05 |
| Normal-vs-Female |
2.207200E-01 |
| Male-vs-Female |
1.513830E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.772300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.333700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.983640E-04 |
| Normal-vs-Age(81-100Yrs) |
3.425200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.292600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.505400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.872800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.428620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.837600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.009000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.881600E-02 |
| Normal-vs-Grade 2 |
7.134600E-01 |
| Normal-vs-Grade 3 |
2.30679999999595E-05 |
| Normal-vs-Grade 4 |
6.2987004501025E-10 |
| Grade 1-vs-Grade 2 |
6.571900E-02 |
| Grade 1-vs-Grade 3 |
4.256100E-03 |
| Grade 1-vs-Grade 4 |
2.02259999999566E-05 |
| Grade 2-vs-Grade 3 |
2.197400E-04 |
| Grade 2-vs-Grade 4 |
4.40740000051676E-09 |
| Grade 3-vs-Grade 4 |
1.081640E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.543000E-01 |
| Normal-vs-ccB subtype |
1.53330000030039E-07 |
| ccA subtype-vs-ccB subtype |
1.03700004139284E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.035760E-02 |
| Normal-vs-N1 |
5.231100E-04 |
| N0-vs-N1 |
1.086070E-02 |
|
|
